Literature DB >> 14571456

Positive salivary gland biopsy, Sjögren syndrome, and neuropathy: clinical implications.

Kenneth C Gorson1, Allan H Ropper.   

Abstract

The relationship between neuropathy and Sjögren syndrome has been predicated largely on sicca symptoms or serological abnormalities rather than salivary gland pathology. We reviewed consecutive neuropathy patients who had had a lip biopsy to identify features of the neuropathy that were associated with a positive lip biopsy suggesting Sjögren syndrome. Twenty of 54 neuropathy patients were biopsy positive; 13 had a painful or nonspecific sensory neuropathy and only 4 were ataxic. Sicca symptoms were not associated with a positive biopsy (P = 0.14). Serological abnormalities were found more often in the biopsy-positive group (P = 0.008), but anti-Sjögren syndrome A or B (anti-SSA or SSB) antibodies were detected in only 30%. There were no other clinical or electromyographic (EMG) features associated with a positive biopsy. From this experience, we conclude that: (1). most patients with neuropathy and a positive lip biopsy for Sjögren syndrome have a painful, distal, sensory axonal neuropathy; (2). there are no clinical or EMG features that are predictive of a positive lip biopsy; (3). ataxic neuropathy is uncommon; and (4). the lack of sicca symptoms or anti-SSA or SSB antibodies in patients with neuropathy does not exclude Sjögren syndrome based upon salivary gland pathology.

Entities:  

Mesh:

Year:  2003        PMID: 14571456     DOI: 10.1002/mus.10470

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  11 in total

Review 1.  Sensory Neuronopathies.

Authors:  Allison Crowell; Kelly G Gwathmey
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-23       Impact factor: 5.081

Review 2.  Inflammatory neuropathies: an update on evaluation and treatment.

Authors:  Lisa D Hobson-Webb; Peter D Donofrio
Journal:  Curr Rheumatol Rep       Date:  2005-10       Impact factor: 4.592

3.  Nuclear-targeting autoantibodies induced nuclear PARP cleavage accompanied by more pronounced decrease of peripheral white blood cells than Ro/SSA and La/SSB antigen-targeting autoantibodies.

Authors:  Ingrid Böhm
Journal:  J Clin Immunol       Date:  2005-03       Impact factor: 8.317

4.  Peripheral nervous system manifestations in systemic autoimmune diseases.

Authors:  Inimioara Mihaela Cojocaru; Manole Cojocaru; Isabela Silosi; Camelia Doina Vrabie
Journal:  Maedica (Buchar)       Date:  2014-09

Review 5.  Immunotherapy Prospects for Painful Small-fiber Sensory Neuropathies and Ganglionopathies.

Authors:  Anne Louise Oaklander
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

6.  Autoimmune neuromuscular disorders.

Authors:  Jessica Kraker; Saša A Zivković
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

Review 7.  Neurology of rheumatologic disorders.

Authors:  Amre Nouh; Olimpia Carbunar; Sean Ruland
Journal:  Curr Neurol Neurosci Rep       Date:  2014-07       Impact factor: 6.030

8.  Sjögren Syndrome-Associated Small Fiber Neuropathy: Characterization From a Prospective Series of 40 Cases.

Authors:  Damien Sène; Patrice Cacoub; François-Jérôme Authier; Julien Haroche; Alain Créange; David Saadoun; Zahir Amoura; Pierre-Jean Guillausseau; Jean-Pascal Lefaucheur
Journal:  Medicine (Baltimore)       Date:  2013-09       Impact factor: 1.889

Review 9.  Minor salivary gland biopsy in Sjögren's syndrome: a review and introduction of a new tool to ease the procedure.

Authors:  Pablo Varela-Centelles; Juan-Manuel Seoane-Romero; Mariña Sánchez-Sánchez; Antonio González-Mosquera; Pedro Diz-Dios; Juan Seoane
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2014-01-01

10.  Comparison of two different labial salivary gland biopsy incision techniques: a randomized clinical trial.

Authors:  Alp Saruhanoğlu; Mert Atikler; Sertan Ergun; Duygu Ofluoğlu; Hakki Tanyeri
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.